OSK3 Antibody

What is OSK3 and how does it relate to rice biology?

OSK3 is a protein found in Oryza sativa (rice), specifically identified in the indica subspecies. It belongs to the OSK family of proteins that function as adaptors in Skp1-Cullin-F-box (SCF) ubiquitin ligase complexes. Similar to OSK1, which is a universal adaptor protein in SCF complexes, OSK3 likely plays a crucial role in protein degradation pathways that regulate plant development and stress responses. The OSK protein family represents the plant homologs of Suppressor of Kinetochore Protein 1 (SKP1) found in other organisms, and they participate in selective protein ubiquitination and subsequent degradation by the 26S proteasome. This process is fundamental to numerous cellular processes including hormone signaling, cell cycle regulation, and immune responses in plants .

What are the technical specifications and optimal storage conditions for OSK3 Antibody?

OSK3 Antibody (such as product code CSB-PA234302XA01OFF) is a rabbit polyclonal antibody raised against recombinant Oryza sativa subsp. indica OSK3 protein. It is supplied in liquid form, typically in a storage buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative. For optimal maintenance of antibody activity, store at -20°C or -80°C and avoid repeated freeze-thaw cycles. The antibody has been validated for ELISA and Western Blot applications for detection of OSK3 in rice samples. As with most research antibodies, it is purified using antigen affinity methods and is recommended for research use only .

How should I optimize Western blot protocols when using OSK3 Antibody?

For optimal Western blot results with OSK3 Antibody, implement the following methodological approach:

• Sample preparation: Extract proteins from rice tissues using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, and protease inhibitor cocktail. Include phosphatase inhibitors if investigating phosphorylation states.

• Protein separation: Use 10-12% SDS-PAGE gels for optimal resolution of OSK3 (approximately 20-25 kDa based on related OSK proteins).

• Transfer conditions: Transfer to PVDF membrane at 100V for 60-90 minutes in cold transfer buffer containing 20% methanol.

• Blocking: Block with 5% non-fat dry milk in TBST for 1-2 hours at room temperature.

• Primary antibody incubation: Dilute OSK3 Antibody 1:1000 in blocking solution and incubate overnight at 4°C with gentle agitation.

• Washing and secondary antibody: Wash 4×5 minutes with TBST, then incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000) for 1 hour.

• Detection: Develop using enhanced chemiluminescence and optimize exposure times based on signal intensity.

This protocol may require optimization based on tissue type, protein abundance, and specific experimental questions, particularly when investigating post-translational modifications or protein-protein interactions .

What controls are essential when studying OSK proteins using antibody-based methods?

When working with OSK3 Antibody, implement these essential controls:

These controls are particularly important given the potential similarity between OSK family members and possible cross-reactivity issues. For phosphorylation studies of OSK proteins, additional controls such as phosphatase treatment should be included to verify phospho-specific signals .

How can I use OSK3 Antibody to investigate protein-protein interactions in SCF complexes?

To investigate OSK3's interactions within SCF complexes:

• Co-immunoprecipitation (Co-IP): Extract proteins using a non-denaturing buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% NP-40, and protease inhibitors. Incubate cleared lysates with OSK3 Antibody overnight, followed by Protein A/G beads. After washing, analyze co-precipitated proteins by Western blot or mass spectrometry to identify SCF components (Cullins, F-box proteins) interacting with OSK3.

• Reciprocal co-IP: Perform immunoprecipitation with antibodies against known SCF components followed by Western blot with OSK3 Antibody to confirm interactions.

• Proximity-dependent labeling: Express OSK3 fused to a biotin ligase (BioID) in rice protoplasts, purify biotinylated proteins, and confirm OSK3 expression using OSK3 Antibody.

• GST pull-down validation: Express GST-tagged OSK3 and potential interactors in a heterologous system, perform pull-downs, and detect interactions using OSK3 Antibody.

• In situ proximity ligation assay: Use OSK3 Antibody in combination with antibodies against potential interactors to visualize protein complex formation in fixed rice tissues.

These methods can reveal whether OSK3 forms complexes similar to those documented for OSK1, which has been shown to interact with jasmonate receptor OsCOI1b in phosphorylation-dependent manner .

What are common technical issues with OSK3 Antibody and how can they be resolved?

For persistent issues, consider testing antibody activity using a direct ELISA against the immunizing antigen or recombinant OSK3 protein to determine if the antibody itself remains functional .

How can I distinguish between signals from OSK3 and closely related OSK proteins?

Distinguishing OSK3 from other OSK family proteins requires multiple complementary approaches:

• Sequence analysis: Compare the epitope region of OSK3 with corresponding regions in other OSK proteins to predict potential cross-reactivity based on sequence similarity.

• High-resolution SDS-PAGE: Use gradient gels (8-15%) to maximize separation based on subtle molecular weight differences between OSK family members.

• 2D electrophoresis: Separate proteins first by isoelectric point then by molecular weight to distinguish OSK proteins with similar sizes but different charges.

• Peptide competition assays: Pre-incubate OSK3 Antibody with synthetic peptides corresponding to the epitope regions of different OSK proteins to determine which specifically blocks binding.

• Mass spectrometry validation: Confirm the identity of immunoprecipitated or Western blot-detected proteins through peptide fingerprinting.

• Expression pattern analysis: Compare detected protein distribution with known tissue-specific expression patterns of different OSK genes from transcriptomic databases.

• Genetic approaches: When available, use knockout/knockdown lines for OSK3 and related OSK proteins as biological controls to verify antibody specificity.

These approaches are particularly important when studying SCF complex formation, as different OSK proteins may participate in distinct complexes with specialized functions .

What methodology should I use to quantify phosphorylation states of OSK proteins?

Based on insights from studies of OSK1 phosphorylation at Ser53, similar approaches can be applied to investigate OSK3 phosphorylation:

• Phospho-specific antibody detection: If available, use phospho-specific antibodies in combination with total OSK3 Antibody to directly measure phosphorylation levels.

• Phos-tag™ SDS-PAGE: Incorporate Phos-tag™ in acrylamide gels to separate phosphorylated from non-phosphorylated forms based on mobility shifts, then detect with OSK3 Antibody.

• λ-phosphatase treatment: Treat protein samples with λ-phosphatase prior to Western blotting to confirm that mobility shifts or multiple bands are due to phosphorylation.

• Mass spectrometry analysis: Immunoprecipitate OSK3 using the antibody, then analyze by mass spectrometry to identify phosphorylation sites and quantify modification stoichiometry.

• In vitro kinase assays: Express recombinant OSK3 and test with candidate kinases, followed by detection with OSK3 Antibody to monitor mobility shifts.

Phosphorylation can significantly alter OSK protein function, as demonstrated with OSK1 where Ser53 phosphorylation specifically increases binding affinity to the jasmonate receptor OsCOI1b and enhances plant susceptibility to pathogens through modulation of jasmonate signaling .

How can OSK3 Antibody be used to study ubiquitination pathways in response to stress?

To investigate how OSK3-containing SCF complexes respond to environmental stresses:

• Stress-induced complex formation: Subject rice plants to various stresses (drought, salinity, pathogen infection), then perform co-immunoprecipitation with OSK3 Antibody followed by mass spectrometry to identify stress-specific interaction partners.

• Substrate identification: Compare ubiquitinated protein profiles between wild-type and OSK3-depleted plants under stress conditions to identify specific substrates of OSK3-containing SCF complexes.

• Temporal dynamics: Collect samples at multiple time points after stress application and analyze OSK3 protein levels, phosphorylation status, and complex formation to establish a temporal map of SCF complex activation.

• Subcellular redistribution: Perform subcellular fractionation followed by Western blot with OSK3 Antibody to track potential stress-induced changes in OSK3 localization.

• PTM crosstalk analysis: Investigate how stress affects OSK3 phosphorylation and how this modification influences SCF complex assembly and activity, similar to documented mechanisms for OSK1.

This approach may reveal OSK3's role in stress-responsive protein degradation pathways, potentially identifying novel mechanisms of plant adaptation similar to those found for OSK1 in jasmonate signaling and stomatal immunity .

What methodological approaches can reveal the relationship between OSK3 and hormone signaling pathways?

To investigate OSK3's role in hormone signaling networks:

• Hormone treatment time-course: Treat rice plants with different hormones (auxin, jasmonate, gibberellin), collect samples at multiple time points, and analyze OSK3 protein levels and phosphorylation status using OSK3 Antibody.

• Co-IP with hormone receptors: Perform co-immunoprecipitation with OSK3 Antibody after hormone treatments to identify potential interactions with hormone receptors or signaling components, similar to the documented interaction between phosphorylated OSK1 and the jasmonate receptor OsCOI1b.

• Ubiquitination assays: After hormone treatment, immunoprecipitate known repressors of hormone signaling (e.g., JAZ proteins for jasmonate, Aux/IAA for auxin) and probe for ubiquitination in the presence and absence (by silencing) of OSK3.

• Degradation kinetics: Perform cycloheximide chase experiments combined with Western blot using OSK3 Antibody to measure OSK3 protein stability under different hormone treatments.

• ChIP-seq integration: If working with transcription factors regulated by OSK3-containing SCF complexes, combine chromatin immunoprecipitation data with OSK3 protein analysis to connect protein degradation with transcriptional reprogramming.

This multi-faceted approach can establish whether OSK3 functions similarly to OSK1, which specifically enhances jasmonate signaling when phosphorylated at Ser53, potentially revealing specialized roles of different OSK proteins in hormone response pathways .

How can I design experiments to study the structural biology of OSK3 and its complexes?

To investigate OSK3 structure and complex formation:

• Epitope mapping: Use proteolytic digestion of recombinant OSK3 followed by Western blot with OSK3 Antibody to identify the precise binding epitope, which helps interpret structural data.

• Co-crystallization studies: Express and purify OSK3 and interaction partners, attempt co-crystallization, and validate resulting structures by generating point mutations that disrupt binding, then confirm using co-IP with OSK3 Antibody.

• Hydrogen-deuterium exchange mass spectrometry: Analyze conformational changes in OSK3 upon binding to different F-box proteins or in response to phosphorylation, using OSK3 Antibody for initial purification.

• Cryo-electron microscopy: Study the architecture of intact SCF complexes containing OSK3, validating complex components with OSK3 Antibody by Western blot.

• FRET-based interaction analysis: Label OSK3 Antibody and antibodies against potential interaction partners with compatible fluorophores to study complex formation in living cells through FRET microscopy.

• Molecular dynamics simulations: Use experimental structures to simulate the effects of phosphorylation on OSK3-partner interactions, then validate predictions using mutant proteins and OSK3 Antibody.

These approaches can illuminate how OSK3 structure relates to its function in SCF complexes and how post-translational modifications like phosphorylation affect these interactions, potentially revealing mechanisms similar to those documented for OSK1 Ser53 phosphorylation .

How should I interpret discrepancies between OSK3 protein levels and gene expression data?

When facing inconsistencies between OSK3 protein abundance detected by antibody-based methods and corresponding mRNA levels:

• Post-transcriptional regulation: Investigate microRNA-mediated regulation or RNA-binding protein interactions that might affect OSK3 mRNA translation efficiency without changing transcript levels.

• Protein stability assessment: Perform cycloheximide chase experiments using OSK3 Antibody to determine if protein turnover rates vary across conditions, explaining discrepancies with stable transcript levels.

• PTM-mediated regulation: Examine whether post-translational modifications affect antibody recognition or protein stability. For instance, if OSK3 undergoes phosphorylation similar to OSK1's Ser53 modification, this might alter epitope accessibility or protein turnover.

• Technical considerations: Validate antibody linearity range, confirm equal loading with multiple controls, and assess whether detection methods for protein and RNA have comparable sensitivity ranges.

• Temporal dynamics: Consider that protein levels often lag behind transcript changes; performing finer time-course analyses may resolve apparent discrepancies.

These investigations can reveal important regulatory mechanisms, as exemplified by OSK1, where phosphorylation dramatically alters protein function in jasmonate signaling without necessarily changing protein abundance .

What statistical approaches should be used when analyzing quantitative data from OSK3 Antibody experiments?

For robust quantitative analysis of OSK3 experiments:

• Sample size determination: Perform power analysis before experiments to determine appropriate biological and technical replicate numbers (minimum n=3 for both).

• Normalization strategies:

  • For Western blots: Normalize to validated housekeeping proteins or total protein stains

  • For immunoprecipitation: Use IgG-normalized recovery efficiency

  • For immunohistochemistry: Use internal controls with known expression patterns

• Statistical tests for different experimental designs:

  • Two-condition comparisons: Paired t-test (parametric) or Wilcoxon signed-rank test (non-parametric)

  • Multiple condition comparisons: One-way ANOVA with appropriate post-hoc tests (Tukey for all pairwise comparisons, Dunnett for comparing to control)

  • Time-course or treatment-course studies: Repeated measures ANOVA or mixed-effects models

• Data visualization:

  • Present mean values with error bars showing standard deviation or standard error

  • Include dot plots showing individual data points alongside bar graphs

  • For correlation analyses, show scatter plots with regression lines and confidence intervals

• Reporting standards:

  • Report exact p-values rather than thresholds

  • Include effect sizes alongside significance values

  • Document all data exclusion criteria and outlier handling procedures

These approaches ensure rigorous quantitative analysis when studying OSK3 in various experimental contexts, similar to analyses performed in studies of related proteins like OSK1 .

How can I integrate OSK3 Antibody data with other -omics approaches for systems-level understanding?

To achieve comprehensive understanding of OSK3 function through multi-omics integration:

• Proteomics correlation: Compare OSK3 protein levels detected by antibody-based methods with global proteomics data to validate measurements and identify co-regulated protein networks.

• Phosphoproteomics integration: Correlate OSK3 phosphorylation status with global phosphoproteomic changes to place OSK3 within signaling networks, particularly in stress responses where OSK1 has demonstrated roles.

• Transcriptome correlation: Identify genes whose expression correlates with OSK3 protein levels or phosphorylation state to infer potential regulatory relationships.

• Ubiquitylome analysis: Compare ubiquitinated protein profiles between wild-type and OSK3-depleted plants to identify potential substrates of OSK3-containing SCF complexes.

• Network analysis approaches:

  • Construct protein-protein interaction networks centered on OSK3

  • Perform pathway enrichment analysis of correlated proteins

  • Use machine learning to identify patterns predictive of OSK3 function

  • Apply differential network analysis to identify condition-specific interactions

• Data visualization tools:

  • Use Cytoscape for network visualization with OSK3 as a focal node

  • Create multi-dimensional plots incorporating protein levels, phosphorylation status, and functional outcomes

  • Develop interactive dashboards for exploring relationships across datasets

This integrative approach positions OSK3 research within broader signaling networks, similar to systems-level analyses that revealed OSK1's role in coordinating jasmonate signaling and stomatal immunity .